Results 211 to 220 of about 21,843 (261)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Heparin Resistance Induced by Intravenous Nitroglycerin. A Word of Caution When Both Drugs Are Used Concomitantly

, 1988
Moh’d A. Habbab, Jacob I. Haft
openalex   +1 more source

Antianginal drugs. Part III. Clinical use of nitroglycerin

American Heart Journal, 1966
openaire   +2 more sources

Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug.

, 1988
Jules Y.T. Lam, James H. Chesebro, Valentı́n Fuster   +2 more
openalex   +1 more source

Drug migration from the adhesive matrix to the polymer film laminate facestock in a transdermal nitroglycerin system

, 1997
Robert J. Markovich, Anne K Taylor, Jack Rosen   +2 more
openalex   +1 more source

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Comparison Between Two Drugs (Propofol and Nitroglycerin as a Hypotensive Agents During Endoscopic Sinus Surgery

, 2020
Case Medical Research
openalex   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Systemic vascular pooling potency of vasodilator drugs (nitroglycerin, phentolamine, hydralazine)

American Heart Journal, 1979
B E, Strauer, A, Scherpe
openaire   +2 more sources

Innovations in research and clinical care using patient‐generated health data

Ca-A Cancer Journal for Clinicians, 2020
H S L Jim, Aasha I Hoogland, Naomi C Brownstein   +2 more
exaly